The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma
- PMID: 17577765
- DOI: 10.1080/10428190701420467
The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma
Comment on
-
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.Leuk Lymphoma. 2007 Jun;48(6):1102-9. doi: 10.1080/10428190701344881. Leuk Lymphoma. 2007. PMID: 17577773
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources